NCT02132702已完成不适用
Performance Attributes and User Progression While Using Ekso Robotic Exoskeleton in an Eight Week, Over Ground, Locomotor Program in Individuals With Spinal Cord Injury
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Ekso Bionics
- 入组人数
- 60
- 试验地点
- 9
- 主要终点
- Number of Participants Adherent to Gait Training Progression Using Ekso
研究概览
简要总结
This study is to evaluate the performance attributes and user progression of participants with motor complete and incomplete spinal cord injury (SCI) while utilizing the Ekso robotic exoskeleton in an eight week over ground, locomotor program. We hypothesize an improvement in progression and overall health while using Ekso.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 15 Years 至 65 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Inpatient or outpatient from 15 through 65 years of age at time of entry into the trial
- •Motor complete (ASIA Impairment Scale [AIS] A and B), with a neurological level of injury (NLI) between C7-L2 (inclusive), or motor incomplete (AIS C and D), NLI C1-L2 (inclusive), as determined by the International Standards for Neurological Classification of SCI (ISNCSCI)
- •Greater than 30 days since SCI occurred
- •Height from 157 - 188 centimeters (5'2" to 6'2") or for individuals who do not meet this criteria the following criteria may be used as assessed per the Ekso operating manual:
- •Max hip width= 16.5" or 42cm Upper leg length= 20" to 24⅛" or 51cm to 61.4cm Lower leg length= 19" to 25" or 48cm to 63.4cm
- •Maximum weight of 100 kilograms (220 pounds)
- •Sufficient upper extremity (UE) strength to use a front wheeled walker (FWW) either by manual muscle testing (MMT) (minimum triceps strength bilaterally of 3/5, shoulder abduction/adduction and flexion/extension 4/5) and/or by functional standing test with FWW. Participants with impaired hand function may use cuff grips.
- •Sufficient range of motion (ROM) to achieve a normal, reciprocal gait pattern, and normal sit to stand transitions.
- •Hip extension greater than or equal to 5 degrees
- •Knee extension greater than or equal to 5 degrees
- •Ankle dorsiflexion greater than or equal to 0 degrees
- •Demonstrate adequate trunk stability and upper extremity strength to utilize Ekso as evidenced by the ability to complete a level (or near level) surface wheelchair to mat transfer with minimal assistance.
- •Medically stable and cleared by a physician for full weight bearing locomotor training including 15 minute standing frame trial to assess standing tolerance
排除标准
- •Have trained in Ekso in the past except for one or two training/demonstration sessions
- •Utilizing another robotic device for locomotor training
- •Any medical issue that in the opinion of the Investigator precludes full weight bearing locomotor training including but not limited to:
- •Spinal instability (or spinal orthotic unless cleared by physician)
- •Acute deep vein thrombosis (DVT) with activity restrictions
- •Severe, recurrent autonomic dysreflexia (AD) requiring medical intervention
- •Heterotopic ossification (HO) in the lower extremities resulting in ROM restrictions at the hips or knees
- •Two or more pathological fractures in the last 48 months in a major weight bearing bone (femur or tibia) in the lower extremity
- •Hip subluxation (x-rays will be obtained for individuals injured prior to 10 years of age)
- •Any medical issue that in the opinion of the Investigator would affect participant safety either due to cognitive deficits/impulsivity, intolerance to mild exercise or other factors
- •Any issue that in the opinion of the Investigator would confound results such as a concurrent neurological injury or disorder (other than SCI) or other factors
- •Modified Ashworth Scale (MAS) = 4 in the majority of lower extremity joints (e.g. greater than or equal to four joint movements in bilateral lower extremities when testing hip flexion/extension, knee flexion/extension, ankle dorsi/plantar flexion)
- •Skin integrity issues in areas that contact the device (including abdominal ostomies) or that would prohibit sitting
- •Pregnancy
研究组 & 干预措施
Ekso treatment
Experimental
干预措施: Ekso (Device)
结局指标
主要结局
Number of Participants Adherent to Gait Training Progression Using Ekso
时间窗: 24 sessions
Participants were scheduled to utilize exoskeleton 3x per week for 8 weeks. The number of participants who completed this dose was tracked.
次要结局
- Cardiovascular Effect(baseline (1st session), session #1, session #12, session #24, followup at 12 weeks. Sessions occur 3x/week over an 8 week training period with a follow up visit at week 12.)
- Impact of Ekso Training on Spasticity(baseline (1st session), session #12, session #24, followup at 12 weeks. Sessions occur 3x/week over an 8 week training period with a follow up visit at week 12.)
- Timed Up and Go (TUG)(baseline (1st session), session #12, session #24, followup at 12 weeks. Sessions occur 3x/week over an 8 week training period with a follow up visit at week 12.)
- Muscle Strength(baseline (1st session), after session #1, session #12, session #24, followup at 12 weeks. Sessions occur 3x/week over an 8 week training period with a follow up visit at week 12.)
- Change in Bladder Function(baseline (1st session), after session #1, session #12, session #24, followup at 12 weeks. Sessions occur 3x/week over an 8 week training period with a follow up visit at week 12.)
- Functional Abilities(baseline, session #12, session #24, followup at 12 weeks. Sessions occur 3x/week over an 8 week training period with a follow up visit at week 12.)
- Change in Bowel Function(baseline (1st session), session #24, followup at 12 weeks. Sessions occur 3x/week over an 8 week training period with a follow up visit at week 12.)
- Quality of Life - Satisfaction of Life(baseline (1st session),session #24, followup at 12 weeks. Sessions occur 3x/week over an 8 week training period with a follow up visit at week 12.)
- Berg Balance Scale (BBS) - Balance(baseline (1st session), session #12, session #24, followup at 12 weeks. Sessions occur 3x/week over an 8 week training period with a follow up visit at week 12.)
- 10 Meter Walk Test - Gait Speed(baseline (1st session), session #12, session #24, followup at 12 weeks. Sessions occur 3x/week over an 8 week training period with a follow up visit at week 12.)
- Gait Progression(baseline (1st session), session #12, session #24, followup at 12 weeks. Sessions occur 3x/week over an 8 week training period with a follow up visit at week 12.)
研究者
研究点 (9)
Loading locations...
相似试验
进行中（未招募）
不适用
Pilates in volleyballAthletic performancemuscle fatiguemuscle strengthinjuriesG11.427.550I03.450.642.845.054E01.370.600.425RBR-8p6zyyniversidade Federal do Triângulo Mineiro
已完成
不适用
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)Diabetes MellitusNCT03730480Ascensia Diabetes Care372
终止
不适用
Evaluation of Assessments of Motor Performance, Physical Impairments and Functional AbilitiesHealthy VolunteersNCT00747955National Institutes of Health Clinical Center (CC)29
终止
不适用
Movement and Fitness Trackers in Determining Performance StatusMalignant NeoplasmNCT03971266University of Southern California31
进行中（未招募）
不适用
Individualized Assessment of Motor Function and Balance in Intensive TherapyNeurodevelopmental DisordersNCT05820412University of Missouri-Columbia30